{"id":2670,"date":"2014-07-30T22:02:00","date_gmt":"2014-07-30T22:02:00","guid":{"rendered":"https:\/\/cdafound.org\/?p=2670"},"modified":"2025-01-16T15:45:20","modified_gmt":"2025-01-16T15:45:20","slug":"global-epidemiology-and-genotype-distribution-of-the-hepatitis-c-virus-infection","status":"publish","type":"post","link":"https:\/\/cdafound.org\/fr\/global-epidemiology-and-genotype-distribution-of-the-hepatitis-c-virus-infection\/","title":{"rendered":"\u00c9pid\u00e9miologie mondiale et distribution g\u00e9notypique de l&#039;infection par le virus de l&#039;h\u00e9patite C"},"content":{"rendered":"<h2 class=\"wp-block-heading\">R\u00e9sum\u00e9<\/h2>\n\n\n\n<p>Le traitement de l&#039;infection chronique par le virus de l&#039;h\u00e9patite C (VHC) a le potentiel de changer consid\u00e9rablement au cours des prochaines ann\u00e9es \u00e0 mesure que les sch\u00e9mas th\u00e9rapeutiques \u00e9voluent rapidement. Cependant, le fardeau de l&#039;infection chronique n&#039;a pas \u00e9t\u00e9 quantifi\u00e9 au niveau mondial \u00e0 l&#039;aide des donn\u00e9es les plus r\u00e9centes. Des estimations mises \u00e0 jour de la pr\u00e9valence, de la vir\u00e9mie et des g\u00e9notypes du VHC sont essentielles pour l&#039;\u00e9laboration de strat\u00e9gies de gestion ou d&#039;\u00e9limination de l&#039;infection par le VHC. Pour y parvenir, une recherche documentaire compl\u00e8te a \u00e9t\u00e9 men\u00e9e sur la pr\u00e9valence anti-VHC, la pr\u00e9valence vir\u00e9mique et les g\u00e9notypes pour tous les pays. Les \u00e9tudes ont \u00e9t\u00e9 incluses en fonction de leur capacit\u00e9 \u00e0 \u00eatre extrapol\u00e9es \u00e0 la population g\u00e9n\u00e9rale, \u00e0 la taille de l&#039;\u00e9chantillon et \u00e0 l&#039;\u00e2ge de l&#039;\u00e9tude. Les estimations nationales disponibles ont \u00e9t\u00e9 utilis\u00e9es pour \u00e9laborer des estimations r\u00e9gionales et mondiales. Quatre-vingt-sept pays ont signal\u00e9 une pr\u00e9valence anti-VHC, tandis que les taux vir\u00e9miques du VHC \u00e9taient disponibles pour 54 pays. Le nombre total d&#039;infections vir\u00e9miques mondiales par le VHC a \u00e9t\u00e9 estim\u00e9 \u00e0 80 (64\u2013103) millions d&#039;infections. La distribution des g\u00e9notypes \u00e9tait disponible pour quatre-vingt-dix-huit pays. \u00c0 l&#039;\u00e9chelle mondiale, le g\u00e9notype 1 (G1) \u00e9tait le plus courant (46%), suivi de G3 (22%), G2 (13%) et G4 (13%). En conclusion, le nombre total d&#039;infections au VHC rapport\u00e9es ici est inf\u00e9rieur aux estimations pr\u00e9c\u00e9dentes. L&#039;exclusion des donn\u00e9es d&#039;\u00e9tudes ant\u00e9rieures men\u00e9es au plus fort de l&#039;\u00e9pid\u00e9mie de VHC, ainsi que les ajustements pour r\u00e9duire la pr\u00e9valence chez les enfants, sont probablement des facteurs contributifs. Les r\u00e9sultats soulignent la n\u00e9cessit\u00e9 d&#039;\u00e9tudes de surveillance plus robustes pour quantifier plus pr\u00e9cis\u00e9ment la charge de morbidit\u00e9 du VHC.<\/p>\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link has-text-color wp-element-button\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25086286\" target=\"_blank\" rel=\"noreferrer noopener\">Lire le rapport complet<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Summary The treatment of chronic hepatitis C virus (HCV) infection has the potential to change significantly over the next few years as therapeutic regimens are rapidly evolving. However, the burden of chronic infection has not been quantified at the global level using the most recent data. Updated estimates of HCV prevalence, viremia and genotypes are [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":3328,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[10],"publication-author":[488,535,1141,494,664],"class_list":["post-2670","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publication","tag-hcv","publication-author-blach-s","publication-author-estes-c","publication-author-gower-e","publication-author-razavi-h","publication-author-razavi-shearer-k"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2670","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/comments?post=2670"}],"version-history":[{"count":5,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2670\/revisions"}],"predecessor-version":[{"id":7624,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2670\/revisions\/7624"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media\/3328"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media?parent=2670"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/categories?post=2670"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/tags?post=2670"},{"taxonomy":"publication-author","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/publication-author?post=2670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}